NCT06921551View on ClinicalTrials.gov

Exploratory Pilot Study on the Prolonged Use of the ABLE Exoskeleton in Multiple Sclerosis

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 7, 2025

Primary Completion Date

May 7, 2026

Study Completion Date

May 7, 2026

Conditions
Multiple Sclerosis
Interventions
DEVICE

ABLE Exoskeleton

Participants will undergo 60-min gait training sessions with the exoskeleton once a week for up to12 months

Trial Locations (1)

28029

RECRUITING

Fundación Esclerosis Múltiple Madrid (FEMM), Madrid

All Listed Sponsors
collaborator

Fundación Esclerosis Múltiple Madrid (FEMM)

UNKNOWN

lead

ABLE Human Motion S.L.

INDUSTRY